K032469

Substantially Equivalent

AESKULISA ANA 8PRO

Applicant: Aesku, Inc.
Product code: LLL
Advisory panel: Immunology
Date received: 2003-08-11
Decision date: 2003-12-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Miami, FL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.